Close

Unusual 11 Mid-Day Movers 7/28: (EVOK) (HWAY) (SPU) Higher; (INFN) (NVCR) (SCKT) Lower

July 28, 2016 12:54 PM EDT

Evoke Pharma (Nasdaq: EVOK) 37.1% HIGHER; Evoke running higher once again on heavy volume. Shares were up over 38 percent at one point today.

Infinera (Nasdaq: INFN) 34.1% LOWER; reported Q2 EPS of $0.21, $0.03 better than the analyst estimate of $0.18. Revenue for the quarter came in at $258.8 million versus the consensus estimate of $255.83 million. "While I am very pleased with our second quarter and year to date financial results, demand is softening in certain areas of our business and we face a difficult near-term revenue outlook," said Tom Fallon, Infinera's Chief Executive Officer

Healthways (Nasdaq: HWAY) 32.8% HIGHER; Sharecare, the digital health company helping people manage all their healthcare in one place, today announced it is acquiring the Population Health business of Healthways, including: Gallup-Healthways Well-Being Index®; Innergy Healthier Weight, a collaboration with Johns Hopkins Medicine that provides a high-touch, personalized solution proven to sustain weight loss; its two Emerging Solutions businesses, Dan Buettner’s Blue Zones Project® and Dr. Ornish’s Program for Reversing Heart Disease™; and Healthways’ stake in Healthways Brasil Servicos de Consultoria Ltda., its Brazil-based joint venture and innovation lab with SulAmerica Servicos de Saude S.A., a subsidiary of the largest independent insurer in Brazil, Sul America S.A.

SkyPeople Fruit Juice, Inc. (Nasdaq: SPU) 27.9% HIGHER; announced that it has formed SkyPeople International Trading (HK) Limited ("SIT"), a subsidiary that has been incorporated in Hong Kong, to operate as a global trading and marketing platform to optimize SkyPeople's Hedetang fruit juice product portfolio and reinforce its leading market position.

PCM, Inc. (Nasdaq: PCMI) 27.8% HIGHER; reported Q2 EPS of $0.66, versus $0.26 reported last year. Revenue for the quarter came in at $581 million, up 21% from last year's $478.87 million. PCM, Inc. sees FY2016 EPS of $1.51 - $1.64. PCM, Inc. sees FY2016 revenue of $2.2 - $2.23 billion.

Grubhub (NYSE: GRUB) 27.0% HIGHER; reported Q2 EPS of $0.23, $0.04 better than the analyst estimate of $0.19. Revenue for the quarter came in at $120.2 million versus the consensus estimate of $114.13 million. Grubhub sees FY2016 revenue of $480 - $488 million, versus the consensus of $473.3 million.

Novocure (Nasdaq: NVCR) 26.0% LOWER; reported Q2 EPS of ($0.48), $0.11 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $17.9 million versus the consensus estimate of $15.9 million.

Socket Mobile (Nasdaq: SCKT) 25.0% LOWER; reported Q2 EPS of $0.09, versus $0.07 reported last year. Revenue for the quarter came in at $5.2 million versus the consensus estimate of $4.5 million.

Alere Inc. (NYSE: ALR) 23.4% HIGHER; announced that it received a U.S. Department of Justice subpoena addressed to Alere Toxicology Services, Inc. on July 1, 2016. The subpoena seeks records related to Medicare, Medicaid and Tricare billings dating back to 2010 for patient samples tested at the Company's Austin, Texas pain management laboratory. The Company is fully cooperating with the investigation. For the first nine months of 2015, Medicare, Medicaid and Tricare billings at the Austin pain management laboratory accounted for significantly less than 1% of Alere's total revenues. Alere believes the matters to which the subpoena relates are not material.

Blucora (Nasdaq: BCOR) 21.4% LOWER; reported Q2 EPS of $0.55, versus $0.35 reported last year. Revenue for the quarter came in at $120.1 million, versus $111.7 million reported last year.

Triumph Group (NYSE: TGI) 20.4% LOWER; reported Q1 EPS of $1.04, $0.10 better than the analyst estimate of $0.94. Revenue for the quarter came in at $893.3 million versus the consensus estimate of $896.88 million. Triumph Group sees FY2017 EPS of $3.15-$3.45, which may not compare to the consensus of $5.01. Triumph Group sees FY2017 revenue of $3.6-3.7 billion, versus the consensus of $3.7 billion.

Cirrus Logic, Inc. (Nasdaq: CRUS) 18.7% HIGHER; reported Q1 EPS of $0.44, $0.16 better than the analyst estimate of $0.28. Revenue for the quarter came in at $259.4 million versus the consensus estimate of $236.37 million. Cirrus Logic, Inc. sees Q2 2017 revenue of $380-420 million, versus the consensus of $322.6 million.

To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Unusual 11 Mid-Day Movers, Earnings